By NATALYA ORTOLANO @NatOrtolanoJULY 1, 2020 An experimental new HIV treatment could, with just one dose, reduce the amount of virus in an infected person for up to six months. But experts aren’t convinced the advance will significantly change how we treat HIV anytime soon. A group of researchers from Gilead Sciences developed a new...
by Asociacion RUVID Scientists from Valencia University (UV) have discovered that Rilpivirine, an antiretroviral drug used for treating HIV, has beneficial effects on chronic liver diseases. The finding opens a path to identify new therapies for liver diseases. Their work has been published in the journal Gut. Liver fibrosis is a significant health issue worldwide...
